Delivery Order SPE2DB20D3103-SPE2DB25FP9U8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,063.52 to AmerisourceBergen Drug Corp for the supply of Bupropion HCL XL 150 mg tablets in quantities of 500 units. This contract, which was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $7,483.78 to AmerisourceBergen Drug Corp for 500 tablets of Bupropion HCL XL 300 mg on August 21, 2025, with completion scheduled for August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive award process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,814.29, is for the supply of Bupropion HCL XL 300 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
- On August 14, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Bupropion HCL XL 150 mg tablets (100 unit dose packages) with a ceiling value of $2,472.49. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $6,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561770702 Bupropion HCl SR 100mg tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 60 count bottles of the specified generic pharmaceutical to a facility in Conshohocken, Pennsylvania between August 10-11, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to...
- The Defense Logistics Agency awarded a $26,640 delivery order to Amerisourcebergen Drug Corporation for 100-count bottles of 100mg bupropion hydrochloride tablets. The firm fixed price order is for product delivery to a facility in Conshohocken, Pennsylvania by September 1, 2023 in support of DLA pharmaceutical procurement programs. Amerisourcebergen will serve as the prime contractor, with performance taking place at its corporate headquarters. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $28,560 to Amerisourcebergen Drug Corporation for the supply of 4561731839 Bupropion HCL XL 150 mg tablets. Under this single award, Amerisourcebergen will deliver 90 tablets to a facility located in Conshohocken, Pennsylvania, with performance required from August 7-8, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's stockpile needs and...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The $6,807.40 firm fixed price order is for the supply of 300 mg bupropion HCl extended-release tablets. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is providing these pharmaceutical products to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical distribution company. The $12,919.84 contract is for the delivery of the pharmaceutical product Bupropion HCL XL 150 mg tablets, with a completion date of February 7, 2024. This award is under a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, valued up to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9U8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Bupropion HCL 100 mg tablets in quantities of 100 units, with a contract value of $1,611.42. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025, and utilized firm fixed-price pricing with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor that supplies a broad range of medications and medical supplies to support military and veteran healthcare systems. The company has demonstrated substantial capability in fulfilling federal medical procurement requirements through open competitive awards, delivering diverse pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order represents a routine transaction within the company's extensive federal contract portfolio with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/21/25 |